A1's Top 5 Most Undervalued Nasdaq Stocks,
Using Our DDDD: (Deep Dive Due Diligence)
5 Stocks With Undeniable
Massive Upside Potential
Updated July 11th, 2025
Let's begin by saying that any investment is risky.
Before investing in anything, do your own due diligence first. Only you can click the "Buy" button.
Anything can happen: When Covid news went worldwide in March 2020, even the greats tumbled:
Tesla fell to $103. Boeing fell to $113 pre-market.
The Stock Market can be quite irrational.
Stocks like HKD can run high, too,
like it did from $10 to $2,550 in just 3 days in 2022.
This is not a "paid advertisement", it is a free service
we offer to our portfolio clients, and share with our followers in the investing public as well.
At A1 we envision a day where stocks become valued by
share price as they should be. The "Correction" is what
we're seeing right now in the Market. Wrongly inflated stocks tumble, money moves to value.
We help investors choose wisely--It's why our readership is steadily increasing.​​
​​Here are our current "Top 5 Most Undervalued Stocks", after our "Deep Dive of Due Diligence":
#1 BCTX BriaCell Therapeutics Corp. Up 3 spots
Today's Headline is s HUGE for BCTX, we are in shock:
:"BriaCell’s Bria-IMT™ Demonstrates Survival Advantage over Trodelvy® and Control Group in Metastatic Breast Cancer ."
Gilead Sciences’ antibody-drug conjugate for metastatic breast cancer and urothelial cancer, Trodelvy®, generated $1.315 billion in global sales in 2024...and this surpasses it in efficacy!
Another PR sent the stock up over $4.50 in seconds:
"BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025" a survival rate breakthrough to be presented the upcoming 2025 American Society of Clinical Oncology (ASCO) Annual Meeting taking place May 30th through
June 3rd at McCormick Place, Chicago, IL.
But as common, the Market turned on it, but created an incredible entry point here:
Curr=$2.08 PT =$18 (865% realistic upside potential.)
​
​​​
#2 HOLO MicroCloud Hologram Inc Inc. NEW!
Claiming in a PR to have purchased $200 million in crypto,
with a paltry MC around $37 million, that alone, if they have zero cash,(doubtful) and zero business(doubtful), the crypto alone gives HOLO's worth a 600% upside!
Curr=$7.19 =$43.20 (600% realistic upside potential.)
​
​#3 EKSO Ekso Bionics Holdings, Inc.
Ekso is on our list due to this outstanding mix of upward pointing reasons: Robotics-Health Care (foremostly spine care, which is the largest $$$ HC industry, see #1 Aclarion).
A.I., a partnership with Nvidia in their prestigious Connect
Program, a very small 2.11 million share float, EXISTING SALES of $17.54 million/yr, and overall decent relative financials:
Per DT: "The company has 9.6 months of cash left based on quarterly cash burn of -$1.97M and estimated current cash of $6.3M." Yahoo Finance gives it an average of a $37.50 longer term price target, also due the major positives Ekso brings.
Curr=$3.38 PT =$16.83 (508% realistic upside potential.)
​
​#4 TRNR Interactive Strength Inc. Up 1 spot
The Wattabike merger is complete, and Sportstech is on deck!...Funding is in place, no further dilution is needed. Now the positive earnings & massive revenue days of TRNR can begin! TRNR is up $2.50/sh since we reported last Friday.
Interactive Strength's FORME Named an Exclusive Wellness Partner for Virgin Atlantic's New Clubhouse at LAX.
Excellent partnership with a massive company, jointly founded by part time "Shark" Richard Branson.
Curr=$7.89 =$32.75 (415% realistic upside potential.)
​
​#5 SHPH Shuttle Pharmaceuticals holding at 5
SHPH has our attention with not only the bargain price
of $4/sh, post RS, but ongoing events as well:
-SHPH shot up like a space shuttle 400% in a previous Friday's pre-market trading...due to the 50% gioblastoma trial enrollment PR. The results from Phase 1 were astounding.
-Also this recent PR: "Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer".
-High "Insider Ownership" is always a very good sign,
SHPH boasts 46.58% plus 5+% institutionally owned.
-Along with our #1 ACON, SHPH also presented in Las Vegas in April. These two life and health enhancing companies have bright futures, and mathematically equal upsides...a first at A1.
A Reverse Split was completed recently, so they're compliant now.
Curr=$3.92 PT =$15 (377% realistic upside potential.)